Prevention of sepsis following endoscopic retrograde cholangiopancreatography
Oral ciprofloxacin was studied as a prophylactic antimicrobial agent in high- and low-risk patients undergoing endoscopic retrograde cholangiography. Ciprofloxacin appeared to be effective, good serum levels were attained, and the drug compared favourably on grounds of cost and convenience with a pa...
Gespeichert in:
| Veröffentlicht in: | The Journal of hospital infection 1991-09, Vol.19, p.65-70 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 70 |
|---|---|
| container_issue | |
| container_start_page | 65 |
| container_title | The Journal of hospital infection |
| container_volume | 19 |
| creator | Alveyn, C.G. Robertson, D.A.F. Wright, R. Lowes, J.A. Tillotson, G. |
| description | Oral ciprofloxacin was studied as a prophylactic antimicrobial agent in high- and low-risk patients undergoing endoscopic retrograde cholangiography. Ciprofloxacin appeared to be effective, good serum levels were attained, and the drug compared favourably on grounds of cost and convenience with a parenterally-administered cephalosporin. |
| doi_str_mv | 10.1016/0195-6701(91)90169-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72553468</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0195670191901699</els_id><sourcerecordid>72553468</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-d56bb1265d775809337a370a5f11e2af8cc2837bfa4d11a0b2ec49caf156d2983</originalsourceid><addsrcrecordid>eNp9kMFKHTEUhkOp2KvtGyjMooguxuZMJslkI4hUW1Dsol2HTHJyTZk7mSZzLb59M9yL3QmBwH--c_j5CDkBegkUxBcKitdCUjhXcKFKomr1jqyAs6ZuFFPvyeoV-UCOcv5NKS05PySHILoWlFyRhx8Jn3GcQxyr6KuMUw658nEY4t8wriscXcw2TsFWCecU18k4rOxTHMy4DnEyo01o5iWfnl4-kgNvhoyf9v8x-XX79efNt_r-8e77zfV9bVkn5tpx0ffQCO6k5F3pxKRhkhruAbAxvrO26ZjsvWkdgKF9g7ZV1njgwjWqY8fkbHd3SvHPFvOsNyFbHEopjNusZcM5a8UCtjvQpphzQq-nFDYmvWigerGoF0V6UaRVeYtFrcra6f7-tt-g-7-001bmn_dzk60ZfCoaQn7FWgayE23BrnYYFhfPAZPONuBo0YWEdtYuhrd7_AODoY87</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72553468</pqid></control><display><type>article</type><title>Prevention of sepsis following endoscopic retrograde cholangiopancreatography</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Alveyn, C.G. ; Robertson, D.A.F. ; Wright, R. ; Lowes, J.A. ; Tillotson, G.</creator><creatorcontrib>Alveyn, C.G. ; Robertson, D.A.F. ; Wright, R. ; Lowes, J.A. ; Tillotson, G.</creatorcontrib><description>Oral ciprofloxacin was studied as a prophylactic antimicrobial agent in high- and low-risk patients undergoing endoscopic retrograde cholangiography. Ciprofloxacin appeared to be effective, good serum levels were attained, and the drug compared favourably on grounds of cost and convenience with a parenterally-administered cephalosporin.</description><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/0195-6701(91)90169-9</identifier><identifier>PMID: 1684197</identifier><language>eng</language><publisher>Kent: Elsevier Ltd</publisher><subject>Administration, Oral ; Bacterial diseases ; Biological and medical sciences ; Cefazolin - administration & dosage ; chemoprophylaxis ; Cholangiopancreatography, Endoscopic Retrograde - adverse effects ; ciprofloxacin ; Ciprofloxacin - administration & dosage ; Ciprofloxacin - therapeutic use ; Double-Blind Method ; Endoscopic retrograde cholangiography ; Female ; Humans ; infection ; Infectious diseases ; Male ; Medical sciences ; Middle Aged ; Risk Factors ; Sepsis - etiology ; Sepsis - prevention & control</subject><ispartof>The Journal of hospital infection, 1991-09, Vol.19, p.65-70</ispartof><rights>1991</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-d56bb1265d775809337a370a5f11e2af8cc2837bfa4d11a0b2ec49caf156d2983</citedby><cites>FETCH-LOGICAL-c386t-d56bb1265d775809337a370a5f11e2af8cc2837bfa4d11a0b2ec49caf156d2983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0195-6701(91)90169-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4317864$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1684197$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alveyn, C.G.</creatorcontrib><creatorcontrib>Robertson, D.A.F.</creatorcontrib><creatorcontrib>Wright, R.</creatorcontrib><creatorcontrib>Lowes, J.A.</creatorcontrib><creatorcontrib>Tillotson, G.</creatorcontrib><title>Prevention of sepsis following endoscopic retrograde cholangiopancreatography</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><description>Oral ciprofloxacin was studied as a prophylactic antimicrobial agent in high- and low-risk patients undergoing endoscopic retrograde cholangiography. Ciprofloxacin appeared to be effective, good serum levels were attained, and the drug compared favourably on grounds of cost and convenience with a parenterally-administered cephalosporin.</description><subject>Administration, Oral</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Cefazolin - administration & dosage</subject><subject>chemoprophylaxis</subject><subject>Cholangiopancreatography, Endoscopic Retrograde - adverse effects</subject><subject>ciprofloxacin</subject><subject>Ciprofloxacin - administration & dosage</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Endoscopic retrograde cholangiography</subject><subject>Female</subject><subject>Humans</subject><subject>infection</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Risk Factors</subject><subject>Sepsis - etiology</subject><subject>Sepsis - prevention & control</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFKHTEUhkOp2KvtGyjMooguxuZMJslkI4hUW1Dsol2HTHJyTZk7mSZzLb59M9yL3QmBwH--c_j5CDkBegkUxBcKitdCUjhXcKFKomr1jqyAs6ZuFFPvyeoV-UCOcv5NKS05PySHILoWlFyRhx8Jn3GcQxyr6KuMUw658nEY4t8wriscXcw2TsFWCecU18k4rOxTHMy4DnEyo01o5iWfnl4-kgNvhoyf9v8x-XX79efNt_r-8e77zfV9bVkn5tpx0ffQCO6k5F3pxKRhkhruAbAxvrO26ZjsvWkdgKF9g7ZV1njgwjWqY8fkbHd3SvHPFvOsNyFbHEopjNusZcM5a8UCtjvQpphzQq-nFDYmvWigerGoF0V6UaRVeYtFrcra6f7-tt-g-7-001bmn_dzk60ZfCoaQn7FWgayE23BrnYYFhfPAZPONuBo0YWEdtYuhrd7_AODoY87</recordid><startdate>19910901</startdate><enddate>19910901</enddate><creator>Alveyn, C.G.</creator><creator>Robertson, D.A.F.</creator><creator>Wright, R.</creator><creator>Lowes, J.A.</creator><creator>Tillotson, G.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910901</creationdate><title>Prevention of sepsis following endoscopic retrograde cholangiopancreatography</title><author>Alveyn, C.G. ; Robertson, D.A.F. ; Wright, R. ; Lowes, J.A. ; Tillotson, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-d56bb1265d775809337a370a5f11e2af8cc2837bfa4d11a0b2ec49caf156d2983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Administration, Oral</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Cefazolin - administration & dosage</topic><topic>chemoprophylaxis</topic><topic>Cholangiopancreatography, Endoscopic Retrograde - adverse effects</topic><topic>ciprofloxacin</topic><topic>Ciprofloxacin - administration & dosage</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Endoscopic retrograde cholangiography</topic><topic>Female</topic><topic>Humans</topic><topic>infection</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Risk Factors</topic><topic>Sepsis - etiology</topic><topic>Sepsis - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alveyn, C.G.</creatorcontrib><creatorcontrib>Robertson, D.A.F.</creatorcontrib><creatorcontrib>Wright, R.</creatorcontrib><creatorcontrib>Lowes, J.A.</creatorcontrib><creatorcontrib>Tillotson, G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alveyn, C.G.</au><au>Robertson, D.A.F.</au><au>Wright, R.</au><au>Lowes, J.A.</au><au>Tillotson, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevention of sepsis following endoscopic retrograde cholangiopancreatography</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>1991-09-01</date><risdate>1991</risdate><volume>19</volume><spage>65</spage><epage>70</epage><pages>65-70</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><abstract>Oral ciprofloxacin was studied as a prophylactic antimicrobial agent in high- and low-risk patients undergoing endoscopic retrograde cholangiography. Ciprofloxacin appeared to be effective, good serum levels were attained, and the drug compared favourably on grounds of cost and convenience with a parenterally-administered cephalosporin.</abstract><cop>Kent</cop><pub>Elsevier Ltd</pub><pmid>1684197</pmid><doi>10.1016/0195-6701(91)90169-9</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0195-6701 |
| ispartof | The Journal of hospital infection, 1991-09, Vol.19, p.65-70 |
| issn | 0195-6701 1532-2939 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72553468 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Administration, Oral Bacterial diseases Biological and medical sciences Cefazolin - administration & dosage chemoprophylaxis Cholangiopancreatography, Endoscopic Retrograde - adverse effects ciprofloxacin Ciprofloxacin - administration & dosage Ciprofloxacin - therapeutic use Double-Blind Method Endoscopic retrograde cholangiography Female Humans infection Infectious diseases Male Medical sciences Middle Aged Risk Factors Sepsis - etiology Sepsis - prevention & control |
| title | Prevention of sepsis following endoscopic retrograde cholangiopancreatography |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T09%3A45%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevention%20of%20sepsis%20following%20endoscopic%20retrograde%20cholangiopancreatography&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=Alveyn,%20C.G.&rft.date=1991-09-01&rft.volume=19&rft.spage=65&rft.epage=70&rft.pages=65-70&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/0195-6701(91)90169-9&rft_dat=%3Cproquest_cross%3E72553468%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72553468&rft_id=info:pmid/1684197&rft_els_id=0195670191901699&rfr_iscdi=true |